EX-23.1 6 dcph-20231231xexx231.htm EX-23.1 Document
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-220866, 333-223992, 333-230270, 333-237031, 333-252904, 333-262595, 333-269614) and Form S-3 (No. 333-271597) of Deciphera Pharmaceuticals, Inc. of our report dated February 7, 2024 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 7, 2024